NCT03975829 2026-05-11Pediatric Long-Term Follow-up and Rollover StudyNovartisPhase 4 Recruiting165 enrolled
NCT03340506 2026-04-20Dabrafenib and/or Trametinib Rollover StudyNovartisPhase 4 Recruiting100 enrolled